Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Therapeutic advances in tremor.
Chronic hepatitis B infection presenting with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
[Fampridine and multiple sclerosis.]
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.
The breakdown of myelin-bound proteins by intra- and extracellular proteases.
Crohn's disease: Is there a place for neurological screening?
Non-protein amino acids and neurodegeneration: The enemy within.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Increased thalamic intrinsic oscillation amplitude in relapsing-remitting multiple sclerosis associated with the slowed cognitive processing.
The effects of salsa dance on gait and balance in multiple sclerosis (p3.053).
A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Pages
« first
‹ previous
…
558
559
560
561
562
563
564
565
566
…
next ›
last »